We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGIH icon
2476
LGI Homes
LGIH
$1.34B
$639K ﹤0.01%
+8,950
New +$621K
DEW icon
2477
WisdomTree Global High Dividend Fund
DEW
$155M
$637K ﹤0.01%
13,746
+420
+3% +$19.4K
FULT icon
2478
Fulton Financial
FULT
$4.65B
$637K ﹤0.01%
38,934
-3,693
-9% -$60.8K
PDBC icon
2479
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.66B
$637K ﹤0.01%
38,943
+1,135
+3% +$18.7K
ACER
2480
DELISTED
Acer Therapeutics Inc
ACER
$637K ﹤0.01%
163,332
+111,410
+215% +$2.12M
KBA icon
2481
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$147M
$635K ﹤0.01%
20,500
+5,540
+37% +$171K
ASH icon
2482
Ashland
ASH
$3.42B
$634K ﹤0.01%
7,932
-1,422
-15% -$110K
JCO
2483
DELISTED
Nuveen Credit Opportunities 2022 Target Term Fund
JCO
$634K ﹤0.01%
66,368
-2,380
-3% -$23.2K
PRO
2484
DELISTED
PROS Holdings
PRO
$633K ﹤0.01%
10,000
STLA icon
2485
Stellantis
STLA
$20.5B
$633K ﹤0.01%
45,343
-295
-0.6% -$4.28K
KN icon
2486
Knowles
KN
$3.29B
$631K ﹤0.01%
34,437
-9,119
-21% -$161K
WNC icon
2487
Wabash National
WNC
$505M
$631K ﹤0.01%
38,786
-13,007
-25% -$192K
FCFS icon
2488
FirstCash
FCFS
$9.04B
$630K ﹤0.01%
6,296
-1,857
-23% -$176K
SR icon
2489
Spire
SR
$4.87B
$630K ﹤0.01%
7,514
-368
-5% -$30.8K
CBT icon
2490
Cabot Corp
CBT
$4.49B
$629K ﹤0.01%
13,179
-522
-4% -$23.5K
JOE icon
2491
St. Joe Company
JOE
$3.89B
$628K ﹤0.01%
36,336
-644
-2% -$10.8K
IGI
2492
Western Asset Investment Grade Defined Opportunity Trust
IGI
$95M
$626K ﹤0.01%
29,902
+8,910
+42% +$185K
COHR icon
2493
Coherent
COHR
$64.3B
$624K ﹤0.01%
17,074
+3,525
+26% +$129K
TUP
2494
DELISTED
Tupperware Brands Corporation
TUP
$624K ﹤0.01%
32,806
+18,461
+129% +$415K
DTD icon
2495
WisdomTree US Total Dividend Fund
DTD
$1.69B
$622K ﹤0.01%
12,792
-70
-0.5% -$3.35K
EWU icon
2496
iShares MSCI United Kingdom ETF
EWU
$4.13B
$622K ﹤0.01%
19,258
+2,804
+17% +$92.3K
AGI icon
2497
Alamos Gold
AGI
$14B
$618K ﹤0.01%
102,712
+2,885
+3% +$14.4K
DIV icon
2498
Global X SuperDividend US ETF
DIV
$773M
$617K ﹤0.01%
27,230
+102
+0.4% +$2.35K
GVA icon
2499
Granite Construction
GVA
$5.49B
$617K ﹤0.01%
12,804
-371
-3% -$16.2K
REI icon
2500
Ring Energy
REI
$357M
$616K ﹤0.01%
189,409
+44,780
+31% +$199K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.